NCT02798536 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- Date treatment consent signed to date off study, approximately 34 months and 19 days for Dose Level 1, 52 months for Dose Level -1, and 42 months and 3 days for Dose Level -2.
- Other-event reporting threshold
- 0%
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Dose Level 1: 170mcg LMB-100 | 1 / 3 | 3 / 3 | 3 / 3 |
| Dose Level -1: 140mcg LMB-100 | 0 / 7 | 7 / 7 | 6 / 7 |
| Dose Level -2: 100mcg LMB-100 + Nab-Paclitaxel | 4 / 11 | 11 / 11 | 11 / 11 |
Serious adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Neoplasms benign, malignant and unspecified (incl cysts and polyps)
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 11
- num Events
- 1
- term
- Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, Death
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Vascular disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 11
- num Events
- 1
- term
- Thromboembolic event
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 11
- num Events
- 3
- term
- Atrial fibrillation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 11
- num Events
- 1
- term
- Creatine phosphokinase (CPK) increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 11
- num Events
- 1
- term
- Fatigue
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Vascular disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 11
- num Events
- 1
- term
- Hypotension
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Musculoskeletal and connective tissue disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 11
- num Events
- 1
- term
- Myositis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 11
- num Events
- 2
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 11
- num Events
- 3
- term
- Small intestinal obstruction
Other reported adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 11
- num Events
- 1
- term
- Abdominal distension
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 11
- num Events
- 2
- term
- Abdominal pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 3
- num Events
- 5
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 7
- num Events
- 8
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 11
- num Events
- 13
- term
- Activated partial thromboplastin time prolonged
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Renal and urinary disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 11
- num Events
- 1
- term
- Acute kidney injury
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 11
- num Events
- 0
- term
- Akathisia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 3
- num Events
- 2
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 7
- num Events
- 6
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 11
- num Events
- 10
- term
- Alanine aminotransferase increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 11
- num Events
- 5
- term
- Alkaline phosphatase increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 11
- num Events
- 1
- term
- Allergic rhinitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 11
- num Events
- 5
- term
- Alopecia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 3
- num Events
- 6
- group Id
- EG001
- num Affected
- 4
- num At Risk
- 7
- num Events
- 22
- group Id
- EG002
- num Affected
- 9
- num At Risk
- 11
- num Events
- 32
- term
- Anemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 3
- num Events
- 2
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 7
- num Events
- 2
- group Id
- EG002
- num Affected
- 5
- num At Risk
- 11
- num Events
- 6
- term
- Anorexia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Psychiatric disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 11
- num Events
- 2
- term
- Anxiety
Complete source fields
- event Groups
- deaths Num Affected
- 3
- deaths Num At Risk
- 3
- description
- Dose Level 1: 170mcg LMB-100 given intravenously on days 1, 3 and 5 of a 21 day cycle for up to 4 cycles.
- id
- EG000
- other Num Affected
- 3
- other Num At Risk
- 3
- serious Num Affected
- 1
- serious Num At Risk
- 3
- title
- Dose Level 1: 170mcg LMB-100
- deaths Num Affected
- 6
- deaths Num At Risk
- 7
- description
- Dose Level -1: 140mcg LMB-100 given intravenously on days 1, 3 and 5 of a 21 day cycle for up to 4 cycles.
- id
- EG001
- other Num Affected
- 7
- other Num At Risk
- 7
- serious Num Affected
- 0
- serious Num At Risk
- 7
- title
- Dose Level -1: 140mcg LMB-100
- deaths Num Affected
- 11
- deaths Num At Risk
- 11
- description
- Dose Level -2: 100mcg LMB-100 + Nab-Paclitaxel given intravenously. LMB-100 given intravenously on days 1, 3 and 5 of a 21 day cycle for up to 2 cycles. Nab-Paclitaxel given intravenously on days 1 and 8 of each 21 day cycle for up to 6 cycles.
- id
- EG002
- other Num Affected
- 11
- other Num At Risk
- 11
- serious Num Affected
- 4
- serious Num At Risk
- 11
- title
- Dose Level -2: 100mcg LMB-100 + Nab-Paclitaxel
- frequency Threshold
- 0
- other Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 11
- num Events
- 1
- term
- Abdominal distension
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 11
- num Events
- 2
- term
- Abdominal pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 3
- num Events
- 5
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 7
- num Events
- 8
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 11
- num Events
- 13
- term
- Activated partial thromboplastin time prolonged
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Renal and urinary disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 11
- num Events
- 1
- term
- Acute kidney injury
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 11
- num Events
- 0
- term
- Akathisia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 3
- num Events
- 2
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 7
- num Events
- 6
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 11
- num Events
- 10
- term
- Alanine aminotransferase increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 11
- num Events
- 5
- term
- Alkaline phosphatase increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 11
- num Events
- 1
- term
- Allergic rhinitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 11
- num Events
- 5
- term
- Alopecia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 3
- num Events
- 6
- group Id
- EG001
- num Affected
- 4
- num At Risk
- 7
- num Events
- 22
- group Id
- EG002
- num Affected
- 9
- num At Risk
- 11
- num Events
- 32
- term
- Anemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 3
- num Events
- 2
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 7
- num Events
- 2
- group Id
- EG002
- num Affected
- 5
- num At Risk
- 11
- num Events
- 6
- term
- Anorexia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Psychiatric disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 11
- num Events
- 2
- term
- Anxiety
- serious Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Neoplasms benign, malignant and unspecified (incl cysts and polyps)
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 11
- num Events
- 1
- term
- Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, Death
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Vascular disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 11
- num Events
- 1
- term
- Thromboembolic event
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 11
- num Events
- 3
- term
- Atrial fibrillation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 11
- num Events
- 1
- term
- Creatine phosphokinase (CPK) increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 11
- num Events
- 1
- term
- Fatigue
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Vascular disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 11
- num Events
- 1
- term
- Hypotension
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Musculoskeletal and connective tissue disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 11
- num Events
- 1
- term
- Myositis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 11
- num Events
- 2
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 11
- num Events
- 3
- term
- Small intestinal obstruction
- time Frame
- Date treatment consent signed to date off study, approximately 34 months and 19 days for Dose Level 1, 52 months for Dose Level -1, and 42 months and 3 days for Dose Level -2.
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle